Alogliptin-Induced Minimal Change Nephrotic Syndrome and Interstitial Nephritis

Alogliptin is one of the dipeptidyl peptidase-4 inhibitors used to treat patients with type 2 diabetes. Little is known about the nephrotoxicity associated with alogliptin, such as nephrotic syndrome or interstitial nephritis. We report a biopsy-proven rare case of minimal change nephrotic syndrome...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Kidney Med
Main Authors: Shima, Hisato, Okamoto, Takuya, Tashiro, Manabu, Inoue, Tomoko, Masaki, Chiaki, Tada, Hiroaki, Takamatsu, Norimichi, Kawahara, Kazuhiko, Okada, Kazuyoshi, Doi, Toshio, Minakuchi, Jun, Kawashima, Shu
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2019
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7380391/
https://ncbi.nlm.nih.gov/pubmed/32734188
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xkme.2019.03.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados